1.120USD-1.74%Mkt Cap: 5.78M USDP/E: —Last update: 2026-06-01
FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline in…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap5.78M USD
Enterprise Value7.04M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-18.65M USD
Revenue/Share—
Last Price1.120 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees15
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.26
PEG—
EV/EBITDA-0.42
EV/Revenue—
P/S—
P/B1.57
EPS (TTM)-7.02
EPS (Forward)-4.49
52W Range
0.95201% of range19.80
52W High19.80 USD
52W Low0.9520 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-302.89%
ROA-193.85%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.39M USD
CapEx (TTM)262.00K USD
FCF Margin—
FCF Yield-148.59%
Net Debt996.00K USD
Net Debt/EBITDA-0.06
Balance Sheet
Debt/Equity0.39
Current Ratio1.59
Quick Ratio0.81
Book Value/Sh0.7400 USD
Cash/Share0.2850 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateMar 30, 2026
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)13.50 USD
Target Range8.000 USD – 19.00 USD
# Analysts2
Ownership
Shares Out.5.21M
Float4.57M
Insiders12.62%
Institutions12.52%
Short Interest
Short Ratio0.6d
Short % Float4.86%
Short % Out.4.56%
Shares Short237.64K
Short (prev mo.)99.97K
Technical
SMA 501.892 (-40.8%)
SMA 2006.332 (-82.3%)
Beta1.19
S&P 52W Chg27.94%
Avg Vol (30d)283.23K
Avg Vol (10d)117.41K
Technical Indicators
RSI (14)36.1
MACD-0.2280
MACD Signal-0.3071
MACD Hist.+0.0791
BB Upper1.400 USD
BB Middle1.147 USD
BB Lower0.8939 USD
BB Width44.14%
ATR (14)0.1478 USD
Vol Ratio (20d)0.11x